| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 16.587 | 32.124 | 32.432 | 23.896 | 31.285 |
| Total Income - EUR | - | - | - | - | - | 16.587 | 32.147 | 32.461 | 23.897 | 31.287 |
| Total Expenses - EUR | - | - | - | - | - | 1.580 | 3.216 | 3.095 | 5.794 | 6.940 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 15.007 | 28.930 | 29.365 | 18.102 | 24.347 |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.533 | 28.063 | 28.489 | 15.281 | 20.306 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr Navolan Marcel S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 587 | 365 | 157 | 0 | 0 |
| Current Assets | - | - | - | - | - | 14.247 | 28.657 | 62.944 | 16.150 | 42.396 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 30.152 | 7.324 | 24.532 |
| Cash | - | - | - | - | - | 14.247 | 28.657 | 32.792 | 8.826 | 17.864 |
| Shareholders Funds | - | - | - | - | - | 14.574 | 28.111 | 28.538 | 15.200 | 20.243 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 260 | 911 | 34.563 | 950 | 22.153 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Navolan Marcel S.r.l.